Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01330849
Other study ID # S52891
Secondary ID
Status Recruiting
Phase N/A
First received April 5, 2011
Last updated April 6, 2011
Start date December 2010
Est. completion date June 2011

Study information

Verified date April 2011
Source Universitaire Ziekenhuizen Leuven
Contact Marina Danckaerts
Phone (+32)16343821
Email marina.danckaerts@uzleuven.be
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the efficacy of the ADHD-Toolkit (a toolkit for school behaviour modification in primary school children with ADHD-behaviours) in terms of general improvement in ADHD symptoms, specific targeted school-related problem behaviours, other disruptive behaviour disorder symptoms, teacher attitudes towards ADHD, teacher-child relationship and child self-esteem.


Description:

Attention-Deficit/Hyperactivity Disorder (ADHD) is a debilitating and common disorder of childhood marked by pervasive and persistent patterns of inattention, overactivity and impulsiveness. It is associated with impairment in a range of domains at both home and school and leads to long term educational and vocational underachievement, delinquency and conduct disorder and social and marital problems. Current treatment approaches involve both pharmacological and non-pharmacological options. Non-pharmacological options tend to focus on home-based approaches such as parent training. These can be effective especially in limiting impairment and reducing symptoms of comorbid problems such as oppositional defiant disorder (ODD) and other psychiatric comorbidities. This can really improve the quality of life of children with ADHD. However, a major problem with these home-based approaches is that their effects are unlikely to generalise to the school setting. This means that to effectively treat ADHD and to deal with impairment at both home and at school one needs to supplement home based approaches with effective school based strategies.

Classroom-based approaches that have been tried with ADHD can be divided into two types (Pelham & Fabiano, 2008). First, there are classroom based management strategies where teachers manipulate the consequences of behaviour to reduce (i.e., negatively reinforce) inappropriate behaviours (aggression, loss of concentration, disruptiveness) and increase (reinforce) appropriate behaviours (compliance, concentration). The second type of intervention focuses on academic targets through manipulating the academic instruction and materials (i.e., reducing task length, peer tutoring). In the current proposal the investigators focus on the first category. Pelham & Fabiano (2008) recently concluded that "the evidence for BCM [behavioural classroom management] for ADHD was substantial".

However, while there is a considerable evidence base for the value of classroom management as a component of ADHD treatment in multi-modal psychosocial treatment packages in school-aged children, there is a lack of well designed randomized studies in a naturalistic school setting that can provide a definitive estimate of efficacy for such approaches.

At the University Hospital of Leuven a toolkit for school behaviour modification in children with ADHD has been developed and piloted. This is an instrument for teachers to systematically target specific behaviours in the classroom and the playground with the ultimate goal of improving school ADHD behaviours and reducing oppositionality. Teachers will identify the behaviours which are most challenging and apply a series of levels of intervention with increasing intensity of monitoring, feedback and training. The effect of a three month application of the toolkit will be evaluated compared to a waiting list control group. Outcome measures will include measures of ADHD behaviours, oppositional defiant behaviour, teacher attitudes towards ADHD, teacher-child relationship and child self-esteem.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 5 Years to 13 Years
Eligibility Inclusion Criteria:

- The teacher must rate the ADHD symptoms of the student above or equal to the 90,9th percentile on the inattention or hyperactivity/impulsivity subscale of the VvGK (a Dutch translation of the Disruptive Behaviour Disorders Rating Scale).

- There is a maximum of 2 children per classroom that may be included.

Exclusion Criteria:

- None (Medication use would not be a reason for exclusion from the sample if children still fulfill the inclusion criteria)(Children with mental retardation (IQ < 70) will automatically be excluded from the study, since the study runs in normal schools.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention-deficit/Hyperactivity Disorder
  • Hyperkinesis

Intervention

Behavioral:
ADHD Toolkit
For children allocated to the active intervention arm, teachers are trained to apply the ADHD Toolkit. Teacher will use the behaviour modification tool for 3 months. They are trained to select target behaviours causing impairment for the child and will apply a systematic approach of increased intensity of monitoring and feedback for the behaviour, including training of appropriate behaviour.
Other:
Waiting List Control group
Children in the control group will receive no specific intervention, but are promised that their teachers will apply the schoolkit for them after the study.

Locations

Country Name City State
Belgium Universitair Ziekenhuis Leuven Leuven Vlaams-Brabant

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary DBD Rating Scale: ADHD subscale, teacher rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated. Evaluation after using the ADHD Toolkit for a three month period No
Secondary DBD Rating Scale: ADHD subscale, parent rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary DBD Rating Scale, oppositional defiant disorder subscale, teacher rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary DBD Rating Scale, oppositional defiant disorder subscale, parent rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary Target Behaviour Improvement Rating Scale, teacher rated Target Behaviour Improvement Rating Scale = a 24-item questionnaire (unpublished) based on the 24 target school behaviours listed in the treatment manual of the ADHD Toolkit (URL: http://www.uzleuven.be/adhd-toolkit), each item is scored on a four-point Likert scale, teacher rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary TRF, subscale internalizing problems TRF = Teacher Report Form (Achenbach, 1991) Evaluation after using the ADHD Toolkit for a three month period No
Secondary CBCL, subscale internalizing problems CBCL= Child Behavior Checklist (Achenbach, 1991) Evaluation after using the ADHD Toolkit for a three month period No
Secondary IRS, teacher rated IRS= Impairment Rating Scale (Fabiano et al, 2006), teacher rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary IRS, parent rated IRS= Impairment Rating Scale (Fabiano et al, 2006), parent rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary Perceived Competence Scale for Children Perceived Competence Scale for Children (Harter, 1985) Evaluation after using the ADHD Toolkit for a three month period No
Secondary Student-Teacher Relationship Scale Student-Teacher Relationship Scale (Pianta, 1991) Evaluation after using the ADHD Toolkit for a three month period No
Secondary Teachers Beliefs and Attitudes towards ADHD Scale, teacher rated Teachers Beliefs and Attitudes towards ADHD Scale = A 20-item questionnaire (unpublished) looking at attributions of cause of ADHD, characteristics of children with ADHD and treatment options for ADHD. This questionnaire is a modification of Charlotte Johnstons ADHD Beliefs and Attitudes Scale [Johnston, C.(2001). ADHD Beliefs and Attitudes Scale. Unpublished scale.]. Scoring on a seven-point Likert scale, teacher rated. Evaluation after using the ADHD Toolkit for a three month period No
Secondary Feasibility, Acceptability and Usefulness Scale, teacher rated Feasibility, Acceptability and Usefulness Scale = A 15-item questionnaire measuring the feasibility, acceptability and usefulness of the ADHD Toolkit intervention, scoring on a five-point Likert scale, teacher rated. This questionnaire was developed specifically for this study (unpublished). Evaluation after using the ADHD Toolkit for a three month period No
Secondary Feasibility, Acceptability and Usefulness Scale, student rated Feasibility, Acceptability and Usefulness Scale = An 11-item questionnaire measuring the feasibility, acceptability and usefulness of the ADHD Toolkit intervention, scoring on a five-point Likert scale, student rated. This questionnaire was developed specifically for this study (unpublished). Evaluation after using the ADHD Toolkit for a three month period No
Secondary DBD Rating Scale, conduct disorder subscale, teacher rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), teacher rated Evaluation after using the ADHD Toolkit for a three month period No
Secondary DBD Rating Scale, conduct disorder subscale, parent rated DBD = Disruptive Behaviour Disorder Rating Scale (Pelham et al, 1992), parent rated Evaluation after using the ADHD Toolkit for a three month period No
See also
  Status Clinical Trial Phase
Completed NCT02251743 - Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD N/A
Completed NCT02226445 - Treatment Drop-out and Missed Appointments Among Adults With ADHD N/A
Completed NCT01342445 - Effects of LDX on Functioning of College Students With ADHD Phase 4
Completed NCT00528697 - A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 2
Not yet recruiting NCT00391495 - Inflammation in Children With Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT00494819 - Validity of ADHD Subtypes Using Neuropsychological Measure N/A
Completed NCT02217371 - Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity N/A
Completed NCT01081132 - Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl Phase 3
Completed NCT06064942 - Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00391729 - A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT00191048 - Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD Phase 4
Terminated NCT00554385 - A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT00997984 - Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) Phase 3
Not yet recruiting NCT05568446 - Social VR Based Intervention on Enhancing Social Interaction Skills in Children With AD/HD N/A
Completed NCT02096952 - Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD Phase 4
Recruiting NCT02623114 - Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers Phase 4
Completed NCT01351246 - Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) N/A
Completed NCT00686933 - Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT00491647 - Time Perception Deficits and Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT01081145 - Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) Phase 3

External Links